BCR-ABL/SRC inhibitor

BCR-ABL and SRC tyrosine kinase inhibitor

Dual kinase inhibition in resistant CML

Drugs with this mechanism (1)

Dasatinib — BCR-ABL/Src inhibitor for CML; pleural effusions.

All mechanisms · Open the interactive console ↗